Medical Devices

Armed with $56 million, Anaconda Biomed is challenging MedTech giants by reimagining mechanical thrombectomy and solving the embolic trap in stroke care.

Mira's new Cortisol Pattern Kit challenges wearable tech by measuring actual biological stress markers in urine, but is more data always better for our health?

Smith+Nephew's newly FDA-cleared LANDMARK knee system pairs 3D-printed implants with compact robotics to target the booming outpatient surgery market.

ABL Texcell Diagnostics’ phased acquisition of Vela’s US and Asian assets highlights a masterclass in post-pandemic medtech consolidation.

Koning Health’s recent TGA approval for its compression-free breast CT system signals a strategic shift in diagnostic imaging and patient compliance.

Sempresto just cleared a key FDA hurdle for its phone-mounted auto-injector. But can attaching life-saving drugs to consumer tech disrupt the allergy market?

A new Southern California distribution deal for an FDA-cleared nerve ablation system could revolutionize treatment for trigeminal neuralgia, but risks remain.

NanoTess co-founders Megan Leslie and Julian Mulia win Canada's Top 40 Under 40 for a catalytic technology that addresses a massive healthcare crisis.

A breakthrough liquid nitrogen ablation device promises to revolutionize cardiac care, but its maker faces a brutal race against dwindling capital.

As specialty drugs strain Canada's healthcare system, a new partnership between Swisslog Healthcare and PharmaSystems aims to deliver advanced cold storage.

Foot Levelers’ new patented Nexi pillow isn't just a product; it's a strategic move to medicalize sleep, using AI and 3D scans to fight modern ills like 'tech neck'.

Following a $26M funding round, Epitel adds a proven commercial leader to its board, signaling a major push to dominate the remote neurology market.

Hyperfine has completed a pivotal study for its portable Swoop MRI. Adding contrast could revolutionize point-of-care diagnostics and unlock major market growth.

Neurodiagnostic giant Natus Medical is localizing production in China, a strategic pivot forced by policy shifts. This move is a blueprint for MedTech survival.

ScoliCare's new Durham clinic taps into a growing demand for non-surgical scoliosis care, challenging traditional treatment models with its tech-driven approach.

New research shows a contactless device can predict worsening asthma by listening for coughs, heralding a new era of proactive, data-driven healthcare.

As AdaptHealth hits the investor circuit, it faces tough questions on profitability, strategy shifts, and recent setbacks. Can leadership reassure the market?

With FDA approval for its RefluxStop® device, Implantica challenges the GERD treatment status quo, promising better outcomes without debilitating side effects.

Glucotrack secures $11.5M to fund a breakthrough diabetes monitor, but a look beneath the surface reveals a high-stakes gamble on AI and shareholder value.

As weight-loss drugs reshape bodies, Aesthetic Management Partners' deal for ATTIVA's subdermal tech signals a pivotal shift in the aesthetic device market.